Back to results
US 9,284,552 B2Granted
Modified cell lines for increasing lentiviral titers
AssigneeGE Healthcare Dharmacon, Inc.
InventorsKatie Jansen Spayd, Jon Karpilow, John K. Wakefield
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a method of modifying cells in order to enhance lentiviral titers, cell lines that are modified and modifying reagents. By mediating individual genes and combination thereof, lentiviral titers may be increased.
Claims19
A method of enhancing lentiviral titers comprising modulating expression of a plurality of host genes in a packaging cell, wherein the modulation comprises”
- a) suppressing expression of Tetherin, and
- b) at least one of
- i) suppressing expression of at least one of Dicer and DGCR8, and
- ii) increasing expression of at least one of TSG101 and Anx2.
1 more element
Dependencies are inferred from the claim text.